Nerissa Kreher Net Worth & Insider Trades

Nerissa Kreher - Chief Medical Officer, Entrada Therapeutics, Inc

As of March 3, 2023

What is Nerissa Kreher's Net Worth?

The current estimated net worth of Entrada Therapeutics, Inc's Chief Medical Officer, Nerissa Kreher, is estimated to be about $652.03K . Nerissa Kreher owns about 41,330 units of Entrada Therapeutics, Inc common stock. In the last 2 years at Entrada Therapeutics, Inc, Nerissa Kreher has sold an estimated value of $602.89K worth.

What is Nerissa Kreher's Past Insider Trading?

Nerissa Kreher's largest purchase order was 13,000 units , worth over $27.3K on October 27, 2022. Nerissa Kreher's largest sale order was 13,000 units , worth over $276.55K on October 27, 2022. In total, Nerissa Kreher has made about 12 transactions over 2 years of their time at Entrada Therapeutics, Inc. Nerissa Kreher usually trades in September, with the busiest year in 2022. The most recent transaction was a sale order of 2,586 units , worth over $28.29K on March 3, 2023.

NERISSA KREHER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Nerissa Kreher's' Mailing Address?

  • Mailing address is C/o Avrobio, Inc. One Kendall Sq., Bldg. 300, Ste. 201 Cambridge MA 02139 MA

What are Entrada Therapeutics, Inc's Past Insider Trades?

Entrada Therapeutics, Inc's most recent insider trade came on March 3, 2023 by James Kory Wentworth who sold 2,752 units worth $30.04K . In the last 2 years, insiders at Entrada Therapeutics, Inc have sold an estimated value of $2.73M and bought an estimated value of $37.14M worth of shares. Insider trading is most common in November, with the busiest year in 2022. The most active traders at the company are Dipal Doshi, President and CEO,  Nathan Dowden, Chief Operating Officer,  and Nerissa Kreher, Chief Medical Officer .

Entrada Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...